Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

PTEN mutations are common in sporadic microsatellite stable colorectal cancer

Abstract

The tumour suppressor gene PTEN, located at chromosome sub-band 10q23.3, encodes a dual-specificity phosphatase that negatively regulates the phosphatidylinositol 3′-kinase (PI3 K)/Akt-dependent cellular survival pathway. PTEN is frequently inactivated in many tumour types including glioblastoma, prostate and endometrial cancers. While initial studies reported that PTEN gene mutations were rare in colorectal cancer, more recent reports have shown an approximate 18% incidence of somatic PTEN mutations in colorectal tumours exhibiting microsatellite instability (MSI+). To verify the role of this gene in colorectal tumorigenesis, we analysed paired normal and tumour DNA from 41 unselected primary sporadic colorectal cancers for PTEN inactivation by mutation and/or allelic loss. We now report PTEN gene mutations in 19.5% (8/41) of tumours and allele loss, including all or part of the PTEN gene, in a further 17% (7/41) of the cases. Both PTEN alleles were affected in over half (9/15) of these cases showing PTEN genetic abnormalities. Using immunohistochemistry, we have further shown that all tumours harbouring PTEN alterations have either reduced or absent PTEN expression and this correlated strongly with later clinical stage of tumour at presentation (P=0.02). In contrast to previous reports, all but one of the tumours with PTEN gene mutations were microsatellite stable (MSI−), suggesting that PTEN is involved in a distinct pathway of colorectal tumorigenesis that is separate from the pathway of mismatch repair deficiency. This work therefore establishes the importance of PTEN in primary sporadic colorectal cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Peterson GM, Kinzler KW, Vogelstein B and de la Chapelle A . (1993). Science, 260, 812–816.

  • Ali IU, Schriml LM and Dean M . (1999). J. Natl. Cancer Inst., 91, 1922–1932.

  • Beahrs OH . (1997). American Joint Committee on Cancer: AJCC Cancer Staging Manual. Lippincott-Raven: Philadelphia, pp. 83–90.

    Google Scholar 

  • Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S . (1998). Cancer Res., 58, 5248–5257.

  • Bonneau D and Longy M . (2000). Hum. Mutat., 16, 109–122.

  • Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS and Sidransky D . (1997). Cancer Res., 57, 4997–5000.

  • Chang JG, Chen YJ, Perng LI, Wang NM, Kao MC, Yang TY, Chang CP and Tsai CH . (1999). Eur. J. Cancer, 35, 647–651.

  • Chung DC . (2000). Gastroenterology, 119, 854–865.

  • Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C and Eng C . (1997). Cancer Res., 57, 4710–4713.

  • Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB and Pandolfi PP . (1999). Science, 285, 2122–2125.

  • Di Cristofano A, Pesce B, Cordon-Cardo C and Pandolfi PP . (1998). Nat. Genet., 19, 348–355.

  • Dicuonzo G, Angeletti S, Garcia-Foncillas J, Brugarolas A, Okrouzhnov Y, Santini D, Tonini G, Lorino G, De Cesaris M and Baldi A . (2001). Clin. Cancer Res., 7, 4049–4053.

  • Downward J . (1998). Curr. Opin. Cell Biol., 10, 262–267.

  • Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C and von Deimling A . (1998). Oncogene, 16, 2259–2264.

  • Elsaleh H . (2001). Gastroenterology, 121, 230–231.

  • Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, Joseph D and Iacopetta B . (2001a). Clin. Cancer Res., 7, 1343–1349.

  • Elsaleh H, Powell B, Soontrapornchai P, Joseph D, Goria F, Spry N and Iacopetta B . (2000). Oncology, 58, 52–59.

  • Elsaleh H, Shannon B and Iacopetta B . (2001b). Gastroenterology, 120, 1309–1310.

  • Eng C . (2000). J. Med. Genet., 37, 828–830.

  • Eng C and Peacocke M . (1998). Nat. Genet., 19, 223.

  • Eng C, Thiele H, Zhou XP, Gorlin RJ, Hennekam RC and Winter RM . (2001). Lancet, 358, 2079–2080.

  • Feilotter HE, Nagai MA, Boag AH, Eng C and Mulligan LM . (1998). Oncogene, 16, 1743–1748.

  • Frayling IM, Bodmer WF and Tomlinson IP . (1997). Cancer Genet. Cytogenet., 97, 64–69.

  • Georgescu MM, Kirsch KH, Akagi T, Shishido T and Hanafusa H . (1999). Proc. Natl. Acad. Sci. USA, 96, 10182–10187.

  • Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ, Ziebold U, Gil E, Hinze R, Delbridge L, Lees JA, Mutter GL, Robinson BG, Komminoth P, Dralle H and Eng C . (2000). Am. J. Pathol., 156, 1693–1700.

  • Giraud S, Choplin H, Teh BT, Lespinasse J, Jouvet A, Labat-Moleur F, Lenoir G, Hamon B, Hamon P and Calender A . (1997). J. Clin. Endocrinol. Metab., 82, 3487–3492.

  • Guanti G, Resta N, Simone C, Cariola F, Demma I, Fiorente P and Gentile M . (2000). Hum. Mol. Genet., 9, 283–287.

  • Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J . (1997). Cancer Res., 57, 3660–3663.

  • Han SY, Kato H, Kato S, Suzuki T, Shibata H, Ishii S, Shiiba K, Matsuno S, Kanamaru R and Ishioka C . (2000). Cancer Res., 60, 3147–3151.

  • Hansen L, Jensen JN, Ekstrom CT, Vestergaard H, Hansen T and Pedersen O . (2001). Diabetologia, 44, 237–240.

  • Ilyas M, Straub J, Tomlinson IP and Bodmer WF . (1999). Eur. J. Cancer, 35, 335–351.

  • Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M . (1993). Nature, 363, 558–561.

  • Kahnoski K, Khoo SK, Nassif NT, Chen J, Lobo GP, Segelov E and Teh BT . (2003). J. Med. Genet., 40, 511–515.

  • Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A . (1997). Nat. Genet., 17, 143–144.

  • Kurose K, Bando K, Fukino K, Sugisaki Y, Araki T and Emi M . (1998). Jpn. J. Cancer Res., 89, 842–848.

  • Kurose K, Zhou XP, Araki T and Eng C . (2000). Genes. Chromosomes Cancer, 29, 166–172.

  • Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P and Pavletich NP . (1999). Cell, 99, 323–334.

  • Li DM and Sun H . (1997). Cancer Res., 57, 2124–2149.

  • Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N and Parsons R . (1998). Cancer Res., 58, 5667–5672.

  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R . (1997). Science, 275, 1943–1947.

  • Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R . (1997). Nat. Genet., 16, 64–67.

  • Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R and Muller CY . (1998). Clin. Cancer Res., 4, 2577–2583.

  • Liu Q and Sommer SS . (1994). PCR Methods Appl., 4, 97–108.

  • Maehama T and Dixon JE . (1998). J. Biol. Chem., 273, 13375–13378.

  • Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, LePrat F, Odent S, Toulouse C, Olopade OI, Sobol H, Tishler S, Woods CG, Robinson BG, Weber HC, Parsons R, Peacocke M, Longy M and Eng C . (1998). Hum. Mol. Genet., 7, 507–515.

  • Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ and Eng C . (1997). Nat. Genet., 16, 333–334.

  • Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham Jr JM, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Tolmie JL, Trembath R, Winter RM, Zackai EH, Zori RT, Weng LP, Dahia PLM and Eng C . (1999). Hum. Mol. Genet., 8, 1461–1472.

  • Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC and Berchuck A . (2000). Clin. Cancer. Res., 6, 2999–3005.

  • Miller SJ, Lou DY, Seldin DC, Lane WS and Neel BG . (2002). FEES Lett., 528, 145–153.

  • Mutter GL, Ince TA, Baak JP, Kust GA, Zhou XP and Eng C . (2001). Cancer Res., 61, 4311–4314.

  • Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP and Eng C . (2000). J. Natl. Cancer Inst., 92, 924–930.

  • Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP and Tonks NK . (1998). Proc. Natl. Acad. Sci. USA, 95, 13513–13518.

  • Negoro K, Takahashi S, Kinouchi Y, Takagi S, Hiwatashi N, Ichinohasama R, Shimosegawa T and Toyota T . (2000). Dis. Colon. Rectum., 43, S29–S33.

  • Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H and Sawyers CL . (2001). Proc. Natl. Acad. Sci. USA, 98, 10314–10319.

  • Okami K, Wu L, Riggins G, Cairns P, Goggins M, Evron E, Halachmi N, Ahrendt SA, Reed AL, Hilgers W, Kern SE, Koch WM, Sidransky D and Jen J . (1998). Cancer Res., 58, 509–511.

  • Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, Komminoth P, Lees JA, Mulligan LM, Mutter GL and Eng C . (1999). Am. J. Pathol., 155, 1253–1260.

  • Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE and Parsons R . (1999). Proc. Natl. Acad. Sci. USA, 96, 1563–1568.

  • Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J . (1997). Cancer Res., 57, 3657–3659.

  • Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA and Das S . (2001). Int. J. Cancer, 91, 22–26.

  • Sarkar G, Yoon HS and Sommer SS . (1992). Genomics, 13, 441–443.

  • Sato K, Tamura G, Tsuchiya T, Endoh Y, Sakata K, Motoyama T, Usuba O, Kimura W, Terashima M, Nishizuka S, Zou T and Meltzer SJ . (2002). Virchows Arch., 440, 160–165.

  • Shin KH, Park YJ and Park JG . (2001). Cancer Lett., 174, 189–194.

  • Singh B, Ittmann MM and Krolewski JJ . (1998). Genes Chromosomes Cancer, 21, 166–171.

  • Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW . (1998). Cell, 95, 29–39.

  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV . (1997). Nat. Genet., 15, 356–362.

  • Taniyama K, Goodison S, Ito R, Bookstein R, Miyoshi N, Tahara E, Tarin D and Urquidi V . (2001). J. Pathol., 194, 341–348.

  • Thibodeau SN, Bren G and Schaid D . (1993). Science, 260, 816–819.

  • Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R . (1997). Cancer Res., 57, 4183–4186.

  • Wang ZJ, Taylor F, Churchman M, Norbury G and Tomlinson I . (1998). Am. J. Pathol., 153, 363–366.

  • Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson III AB and Hamilton SR . (2001). N. Engl. J. Med., 344, 1196–1206.

  • Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK and Eng C . (2002). Int. J. Cancer, 99, 63–67.

  • Wu X, Senechal K, Neshat MS, Whang YE and Sawyers CL . (1998). Proc. Natl. Acad. Sci. USA, 95, 15587–15591.

  • Yu K, Toral-Barza L, Discafani C, Zhang WG, Skotnicki J, Frost P and Gibbons JJ . (2001). Endocr. Relat. Cancer, 8, 249–258.

  • Zhou XP, Gimm O, Hampel H, Niemann T, Walker MJ and Eng C . (2000). Am. J. Pathol., 157, 1123–1128.

  • Zhou XP, Kuismanen S, Nystrom-Lahti M, Peltomaki P and Eng C . (2002a). Hum. Mol. Genet., 11, 445–450.

  • Zhou XP, Li YJ, Hoang-Xuan K, Laurent-Puig P, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G and Hamelin R . (1999). Int. J. Cancer, 84, 150–154.

  • Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomaki P, de la Chapelle A, Aaltonen LA and Eng C . (2002b). Am. J. Pathol., 161, 439–447.

Download references

Acknowledgements

We thank the surgeons who contributed samples to the South West Sydney Colorectal Tumour Bank. We also thank Associate Professor Robyn Ward and Dr Helen Rizos for their helpful comments on the manuscript. This work was supported by grants from the South West Sydney Bowel Cancer Foundation and Colorectal Tumour Group, the Cancer Therapy Centre at Liverpool Hospital and a scholarship from the South West Sydney Clinical School of the University of New South Wales (to GPL). CE is a recipient of the Doris Duke Distinguished Clinical Scientist Award.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Najah T Nassif or Eva Segelov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nassif, N., Lobo, G., Wu, X. et al. PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene 23, 617–628 (2004). https://doi.org/10.1038/sj.onc.1207059

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207059

Keywords

This article is cited by

Search

Quick links